Skip to main content
OpenTrials
Completed

NCT Number: NCT05521919

Acute Plasma Abeta Responses to Stress

Research has shown that activation of the sympathetic nervous system for extended periods or during certain times in life can increase the risk for Alzheimer's disease. Some research in animal models show that acute activation of the sympathetic nervous system through stress exposure can increase certain Alzheimer's disease-related biomarkers, such as amyloid-beta, within hours of exposure. However, how acute sympathetic nervous system activation via stress exposure affects amyloid-beta levels in humans has yet to be examined.

In this study, the investigators will examine whether brief increases in sympathetic activation result in immediate changes in plasma amyloid-beta levels in the five hours after exposure.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Southern California

Los Angeles, California, 90089, United States

About this study

Aim 1: determine whether acute exposure to stress (increasing sympathetic nervous system activation) increases plasma amyloid-beta-40 and amyloid-beta-42 in the five hours following exposure.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Healthy adult weighing at least 110 pounds
  • No chronic conditions or illness
  • Taking no medications or drugs that might alter the stress response (e.g., corticosteroids, beta-blockers, and others)
  • Not using any hormone-containing medication (e.g., hormonal contraceptives, hormone replacement, etc.)
  • No contraindications for cold pressor test exposure (high blood pressure, heart disease, dysrhythmia, peripheral vascular disease, any other cardiovascular disorder, diabetes, vasculitis, lupus, tingling or numbness in the hands and/or feet, cryoglobulinemia, and Reynaud's phenomenon)
  • No history of fainting during blood draws
  • No phobia of having their blood drawn
  • No general history of fainting or seizures
  • Not currently diagnosed with a mood disorder (e.g., major depressive disorder)
  • Not pregnant in the past 12 months
  • Not lactating in the past 12 months
  • Not trying to become pregnant if premenopausal
  • Experienced natural menopause if postmenopausal
  • Be non-smokers
  • Be fluent in English

Exclusion criteria

  • Unwilling to be filmed during the stress task OR unwilling to sign the waiver allowing their filmed responses to be used in scientific presentations

Treatment and study plan

Sympathetic Nervous System Activation

Behavioral

Participants will complete a task that increases sympathetic nervous system activation.

No-stress

Behavioral

Participants will complete a task that will not affect their sympathetic nervous system activity.

Primary outcomes

  1. Plasma amyloid-beta-40

    Time frame: 9.5 hours

    Changes in levels of amyloid-beta-40 in blood from before to after acute intervention (stress/no-stress).

  2. Plasma amyloid-beta-42

    Time frame: 9.5 hours

    Changes in levels of amyloid-beta-42 in blood from before to after acute intervention (stress/no-stress).

Sponsors and collaborators

Lead sponsor

University of Southern California

Other

Collaborators

  • Keck School of Medicine of USC
  • Washington University School of Medicine

Registry information

Official study title

Effects of Acute Stress Exposure on Plasma Beta-amyloid Levels

Important dates

Study start
2023
Primary completion
2024
Study completion
2024
First posted
Aug 30, 2022
Registry last updated
Dec 10, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.